Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Natures Sunshine Products | NATR | Dec 24, 2024 | 15.08 | -0.46 |
Natuzzi ADR | NTZ | Dec 24, 2024 | 4.70 | +17.50 |
NatWest ADR | NWG | Dec 24, 2024 | 10.25 | +1.08 |
Nauticus Robotics | KITT | Dec 24, 2024 | 1.14 | +11.76 |
Nautilus Biotechnology | NAUT | Dec 24, 2024 | 1.73 | +0.58 |
Navidea Biopharmaceuticals | NAVB | Dec 24, 2024 | 0.00 | 0.00 |
Navient | NAVI | Dec 24, 2024 | 13.52 | +2.11 |
Navigator Holdings | NVGS | Dec 24, 2024 | 15.28 | +0.92 |
Navios Maritime Partners LP Unit | NMM | Dec 24, 2024 | 44.52 | +0.29 |
Navitas Semiconductor | NVTS | Dec 24, 2024 | 3.98 | +3.11 |
Naya Biosciences | NAYA | Dec 24, 2024 | 0.78 | 0.00 |
Nayax | NYAX | Dec 24, 2024 | 28.00 | +1.82 |
NB Bancorp | NBBK | Dec 24, 2024 | 18.77 | +1.13 |
NBT Bancorp | NBTB | Dec 24, 2024 | 49.19 | +0.43 |
Ncino | NCNO | Dec 24, 2024 | 35.27 | +0.26 |
NCR | VYX | Dec 24, 2024 | 14.28 | +2.59 |
NCR Atleos When Issued | NATL | Dec 24, 2024 | 34.18 | +0.65 |
NCS Multistage | NCSM | Dec 24, 2024 | 24.49 | 0.00 |
Nebius Group | NBIS | Dec 24, 2024 | 28.25 | 0.00 |
Nektar Therapeutics | NKTR | Dec 24, 2024 | 0.91 | +0.81 |
Nelnet | NNI | Dec 24, 2024 | 106.35 | +1.42 |
Neogen | NEOG | Dec 24, 2024 | 12.22 | +0.83 |
NeoGenomics | NEO | Dec 24, 2024 | 17.15 | +3.75 |
Neonode | NEON | Dec 24, 2024 | 8.30 | +1.59 |
NeoVolta | NEOV | Dec 24, 2024 | 4.74 | +2.82 |
Nephros | NEPH | Dec 24, 2024 | 1.49 | +0.34 |
NerdWallet A | NRDS | Dec 24, 2024 | 13.17 | +2.57 |
Nerdy A | NRDY | Dec 24, 2024 | 1.69 | 0.00 |
Net Lease Office Properties When Issued | NLOP | Dec 24, 2024 | 30.89 | +0.59 |
Net Power A | NPWR | Dec 24, 2024 | 10.20 | +2.10 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.